Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherThis Month in JNM

THIS MONTH IN JNM

Journal of Nuclear Medicine April 2005, 46 (4) 8a-9a;
  • Article
  • Info & Metrics
  • PDF
Loading

Otani and colleagues explore the relationship between myocardial 11C-DAG accumulation assessed by PET and left ventricular enlargement, systolic dysfunction, and humoral activation after myocardial infarction.

Page 553

Ribeiro and colleagues use 18F-fluoro-l-DOPA PET to detect hyperfunctional pancreatic islet tissue and distinguish between the diffuse and focal forms of hyperinsulinism in infants.

Page 560

Figure

Akhtar and colleagues evaluate the scintigraphic imaging potential of 99mTc-ubiquicidin 29-41, a synthetic antimicrobial peptide fragment, for localizing foci of infection in human bone and soft tissues.

Page 567

Minutoli and colleagues report on the effect of timing differences on the reliability of 99mTc-MIBI SPECT imaging in differentiating neoplastic from nonneoplastic intraparenchymal cerebral hemorrhage.

Page 574

Hockaday and colleagues assess imaging and biodistribution data from a phase I/II trial of intracavitary 131I-TM-601 in patients with recurrent high-grade glioma to determine whether this radiolabeled compound might be useful in estimating the extent of primary brain tumor.

Page 580

Kim and colleagues compare inline PET/CT with dedicated PET and with software fusion of independently acquired CT and PET scans for staging of recurrent colorectal cancer.

Page 587

Beyer and colleagues report on the efficacy of several support structures and placements in reducing the likelihood of patient motion in the head and neck during whole-body PET/CT studies.

Page 596

Figure

Halpern and colleagues characterize optimal lutetium orthosilicate PET imaging protocols to meet the challenges of lesion detection in obese patients.

Page 603

Brix and colleagues use a phantom to assess the radiation exposure of patients undergoing whole-body 18F-FDG PET/CT examinations at 4 hospitals with different tomographs and imaging protocols and describe possible strategies to reduce exposure while maintaining quality.

Page 608

Figure

Parsey and colleagues investigate human biodistribution and dosimetry of the PET serotonin 1A antagonist 11C-WAY100,635 and discuss the importance of human dosimetry studies in the development of new radiotracers.

Page 614

Sharkey and colleagues describe the pharmacokinetics, dosimetry, and dose-limiting toxicity of a support protocol for patients with advanced medullary thyroid cancer, including humanized anticarcinoembryonic antigen or monoclonal antibody combined with doxorubicin and peripheral blood stem cell support.

Page 620

Vallabhajosula and colleagues compare the pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody in patients with prostate cancer and estimate the radiation dosimetry of 90Y-J591 to assess the utility of 111In as a chemical and biologic surrogate for 90Y.

Page 634

Figure

Shen and colleagues detail the patient-specific dosimetry of pretargeted 90Y/111In-DOTA-biotin after CC49 fusion protein in patients with metastatic gastrointestinal cancer.

Page 642

Lee and colleagues evaluate the feasibility of sodium-iodide (NIS) symporter gene imaging with radioiodide scintigraphy for assessing myocardial gene expression in a rat model by using a dual-gene adenovirus that expresses both NIS protein and enhanced green fluorescent protein.

Page 652

Figure

Yagle and colleagues investigate 18F-annexin V binding to apoptotic tissues in a model of chemically induced apoptosis in rat liver and discuss the potential of this radiolabeled protein for early, individualized PET assessment of clinical response to cancer therapy.

Page 658

Wang and colleagues combine bioluminescence and microPET modalities to elucidate the utility of homeodomain protein SIRES bicistronic vectors for improved assessment of therapeutic gene expression based on reporter gene expression in living subjects.

Page 667

Zhao and colleagues describe the intratumoral distribution of 18F-FDG and compare it with regional expression levels of glucose transporters and hexokinase-II in a rat model of malignant tumor.

Page 675

Vavere and Welch outline the biodistribution and microPET imaging characteristics of 45Ti-transferrin in a mouse model to provide insight into the action of titanocene dichloride, a chemotherapeutic agent now in clinical trials.

Page 683

Schuhmacher and colleagues report on a study in mice evaluating a novel bombesin analog labeled with 68Ga for gastrin-releasing peptide receptor imaging with PET.

Page 691

Pozzi and Zalutsky detail the results of experiments to identify the phenomena responsible for difficulties in 211At-labeled antibody synthesis at high radiation doses and the solvent-related effects that may be relevant to synthesis of other therapeutic radiopharmaceuticals.

Page 700

Aubert-Broche and colleagues compare and evaluate 4 methods for SPECT detection of interhemispheric asymmetries of brain perfusion in epilepsy, with special attention to the relative merits of quantitative assessment and visual inspection.

Page 707

ON THE COVER

Because cardiac gene therapy entails multiple complex steps, including delivery and expression of transgenes, interest is increasing in noninvasive methods of monitoring myocardial gene expression. The need for PET scanners and on-site radiochemical synthesis limits widespread application of radioprobes that specifically target proteins produced by the transgene of interest. More accessible instruments and simple radioprobes have been under study, such as the use of γ-cameras and free radioiodide to study the sodium/iodide symporter (NIS) gene. A dual-gene vector that included the NIS gene as a reporter gene appeared to allow accurate assessment of the level of myocardial expression of a second gene of interest.

Figure
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (4)
Journal of Nuclear Medicine
Vol. 46, Issue 4
April 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
THIS MONTH IN JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
THIS MONTH IN JNM
Journal of Nuclear Medicine Apr 2005, 46 (4) 8a-9a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
THIS MONTH IN JNM
Journal of Nuclear Medicine Apr 2005, 46 (4) 8a-9a;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Myocardial 11C-Diacylglycerol Accumulation and Left Ventricular Remodeling in Patients After Myocardial Infarction
  • Characterization of Hyperinsulinism in Infancy Assessed with PET and 18F-Fluoro-l-DOPA
  • Antimicrobial Peptide 99mTc-Ubiquicidin 29–41 as Human Infection-Imaging Agent: Clinical Trial
  • Timing of Examination Affects Reliability of 99mTc-Methoxyisobutylisonitrile SPECT in Distinguishing Neoplastic from Nonneoplastic Brain Hematomas
  • Imaging Glioma Extent with 131I-TM-601
  • Comparison Between 18F-FDG PET, In-Line PET/CT, and Software Fusion for Restaging of Recurrent Colorectal Cancer
  • On the Use of Positioning Aids to Reduce Misregistration in the Head and Neck in Whole-Body PET/CT Studies
  • Optimizing Imaging Protocols for Overweight and Obese Patients: A Lutetium Orthosilicate PET/CT Study
  • Radiation Exposure of Patients Undergoing Whole-Body Dual-Modality 18F-FDG PET/CT Examinations
  • Biodistribution and Radiation Dosimetry of 11C-WAY100,635 in Humans
  • A Phase I Trial Combining High-Dose 90Y-Labeled Humanized Anti-CEA Monoclonal Antibody with Doxorubicin and Peripheral Blood Stem Cell Rescue in Advanced Medullary Thyroid Cancer
  • Pharmacokinetics and Biodistribution of 111In- and 177Lu-Labeled J591 Antibody Specific for Prostate-Specific Membrane Antigen: Prediction of 90Y-J591 Radiation Dosimetry Based on 111In or 177Lu?
  • Patient-Specific Dosimetry of Pretargeted Radioimmunotherapy Using CC49 Fusion Protein in Patients with Gastrointestinal Malignancies
  • Accuracy of Myocardial Sodium/Iodide Symporter Gene Expression Imaging with Radioiodide: Evaluation with a Dual-Gene Adenovirus Vector
  • Evaluation of 18F-Annexin V as a PET Imaging Agent in an Animal Model of Apoptosis
  • Noninvasive Monitoring of Target Gene Expression by Imaging Reporter Gene Expression in Living Animals Using Improved Bicistronic Vectors
  • Biologic Correlates of Intratumoral Heterogeneity in 18F-FDG Distribution with Regional Expression of Glucose Transporters and Hexokinase-II in Experimental Tumor
  • Preparation, Biodistribution, and Small Animal PET of 45Ti-Transferrin
  • GRP Receptor-Targeted PET of a Rat Pancreas Carcinoma Xenograft in Nude Mice with a 68Ga-Labeled Bombesin(6–14) Analog
  • Radiopharmaceutical Chemistry of Targeted Radiotherapeutics, Part 1: Effects of Solvent on the Degradation of Radiohalogenation Precursors by 211At α-Particles
  • Evaluation of Methods to Detect Interhemispheric Asymmetry on Cerebral Perfusion SPECT: Application to Epilepsy
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire